Strong Industry Focus marketRx specializes in analytics and software services for the global Life Sciences sector, including pharmaceuticals, biotechnology, and medical devices, indicating opportunities to offer tailored solutions or upgrades to companies within these niches.
Recent AI and Cybersecurity Initiatives Recent investments in developing industry-specific AI solutions in partnership with Microsoft and the launch of a Next-Gen Cyber Defense Center demonstrate a commitment to advanced technological capabilities, opening avenues to provide complementary AI and cybersecurity services.
Growth Through Acquisition As part of Cognizant since 2007, marketRx’s integration into a larger enterprise suggests potential for upselling enterprise-scale digital transformation and consultancy services to other Cognizant clients or similar organizations.
Emerging Legal Risks Recent class-action lawsuits related to data breaches and failure to disclose breaches highlight potential opportunities in cybersecurity, compliance, and risk mitigation services for life sciences and healthcare clients seeking to strengthen their data protections.
Client Acquisition & Expansion Cognizant's recent client wins like Bupa Hong Kong and ERIKS Group indicate ongoing efforts to expand their healthcare and industrial client base, offering prospects to introduce specialized analytics, AI enhancements, or managed services tailored to these sectors.
$10B
$10B
$10B
$10B
$10B
$10B
$10BmarketRx uses 8 technology products and services including 3DEXPERIENCE Platform, jsDelivr, ServiceNow Software Asset Management, and more. Explore marketRx's tech stack below.
| marketRx Email Formats | Percentage |
| FLast@marketrx.com | 91% |
| FiLast@marketrx.com | 9% |
| First.Last@cognizant.com | 90% |
| First.L@cognizant.com | 8% |
| First-Last@cognizant.com | 1% |
| Last.First@cognizant.com | 1% |
Business Consulting and ServicesUnited States51-200 Employees
marketRx, Inc. was a leading provider of analytics and related software services to global Life Sciences companies in the pharmaceuticals, biotechnology and medical devices segments. It was acquired by Cognizant (NASDAQ: CTSH) in 2007 and has been integrated into the Cognizant brand.
Company Overview
Media & News
Funding & FinancialsmarketRx's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsmarketRx's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com